Ana Edileia Barbosa Pereira Leal

Ana Edileia Barbosa Pereira Leal

Auto-generated profile, based on publicly available information

Ana Edileia Barbosa Pereira Leal

Postgraduate Program in Biotechnology, State University of Feira de Santana, Feira de Santana, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2022 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ALAna Ediléia Barbosa Pereira Leal
Ana Ediléia Barbosa Pereira Leal
ÉLÉrica Martins de Lavor
Érica Martins de Lavor
JBJackson de Menezes Barbosa
Jackson de Menezes Barbosa
MAMaria Taís de Moura Fontes Araújo
Maria Taís de Moura Fontes Araújo
CACristiane dos Santos Cerqueira Alves
Cristiane dos Santos Cerqueira Alves
JAJackson Almeida
Jackson Almeida
Background: Passiflora L. is a genus belonging to the Passifloraceae family, with many species widely used in folk medicine and several pharmacological activities described in the scien-tific literature, being a major target for the development of new therapeutic products. Studies have identified several bioactive compounds in their composition as responsible for these activities, mainly C-glycoside flavonoids. Objective: The aim of this study was to carry out a review of patents related to the genus and its ap-plication in several pharmacological activities, important for the development of new drugs and formulations. Method: The search was carried out in 5 specialized databases, INPI, EPO, WIPO, Latipat and Derwent, using the term ‘Passiflora’ combined with ‘A61K and A61P', subclasses of section A of the International Patent Classification (IPC), which are destined to medical, dental or hygienic pur-poses, and therapeutic activity of chemical compounds or medicinal preparation, respectively. Results: 1,198 patents citing the genus in the title or abstract have been found, 508 being duplicates. After exclusion and inclusion criteria, 23 patents written in English, Portuguese and Spanish were selected, which demonstrated biological assays in vivo with species of Passiflora as the only active constituent or incorporated in formulations with other compounds. Conclusion: The findings of this search showed growing interest in research and industrial areas in the pharmaceutical development with species of Passiflora, suggesting that the different bioactive compounds present in the genus can be considered as an important tool for the development of new effective and safe products with pharmacological potential.

3 July 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
ISIsamara Ferreira da Silva
Isamara Ferreira da Silva
ALAna Edileia Barbosa Pereira Leal
Ana Edileia Barbosa Pereira Leal
GRGiovanna Nogueira da Silva Avelino Oliveira Rocha
Giovanna Nogueira da Silva Avelino Oliveira Rocha
JBJackson de Menezes Barbosa
Jackson de Menezes Barbosa
NSNadja Batista dos Santos
Nadja Batista dos Santos
JAJackson Almeida
Jackson Almeida
O tratamento de enfermidades à base de plantas medicinais é uma prática antiga e que vem ganhando especial atenção na área da ciência médica, sobretudo, na medicina veterinária, onde vários estudos científicos já comprovaram a eficácia de inúmeras plantas como possível alternativa ao uso de fármacos convencionais. Nesta perspectiva, o objetivo dessa revisão de literatura foi reunir estudos científicos realizados no Brasil sobre a eficácia terapêutica de plantas medicinais com possível aplicação na medicina veterinária. Para tal, foram selecionados 114 artigos (pesquisados nas bases de dados Google Acadêmico, SciELO, PubMed, Science Direct e MEDLINE) para compor essa revisão. Foram comprovadas as atividades biológicas de mais de 70 plantas, concluindo-se que as plantas são alternativas eficientes e seguras para o tratamento de doenças na medicina veterinária.